Rutin attenuates Sorafenib-induced Chemoresistance and Autophagy in Hepatocellular Carcinoma by regulating BANCR/miRNA-590-5P/OLR1 Axis

Rutin, the main component of Potentilla discolor Bunge, was proven to exhibit anti-tumor properties. Sorafenib (SO) is conventionally used in chemotherapy against hepatocellular carcinoma (HCC), but acquired resistance developed during long-term therapy limits its benefits. This study aimed to explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Meng, Zhang, Gan, Hu, Jun, Zhu, Yanzhi, Lan, Haoming, Shen, Xianfeng, Lv, Yi, Huang, Linsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416719/
https://www.ncbi.nlm.nih.gov/pubmed/34512168
http://dx.doi.org/10.7150/ijbs.62471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416719/
https://www.ncbi.nlm.nih.gov/pubmed/34512168
http://dx.doi.org/10.7150/ijbs.62471

Ejemplares similares